New Treatment for Widespread Parasitic Infections: Phase II-III Trial Demonstrates Safety and Enhanced Efficacy
Researchers are heralding a significant breakthrough in the fight against intestinal parasites that afflict approximately 1.5 billion people globally. The completion of a Phase II-III...